Additionally, the anti-apoptotic signals stimulated by STAT3 contribute to the limited response of breast cancer cells to HDAC inhibitors and the HER2 inhibitor lapatinib (Zeng et al., 2016). Here, HDAC9 is linked to breast carcinoma.